Delivery Order SPE2DB24D2205-SPE2DB24FDWXC
Award Date
7/16/24
Potential Completion Date
7/17/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order worth $11,191.84 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a completion date of May 22, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,540.33, is a Delivery Order for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of December 19, 2023 and is a Firm Fixed Price contract. The contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of XIFAXAN 550 MG TABLET 60S. The contract has a ceiling value of $17,572.67 and runs through May 30, 2024. It is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $6,638.50 firm fixed-price delivery order is for XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of July 24, 2024 and was awarded on July 23, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,379.84, is a Delivery Order for the supply of XIFAXAN 550 mg tablets. The contract has a Firm Fixed Price pricing type and an ultimate completion date of May 13, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of XIFAXAN 550 mg tablets in 60-count units. The $3,408.47 firm fixed price delivery order has an ultimate completion date of November 20, 2024. The contract is not designated with a set-aside requirement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order for the supply of XIFAXAN 550 mg tablets, a brand name pharmaceutical product. The contract has a ceiling value of $12,640.22 and a period of performance through April 1, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery...
This federal contract award, valued at $30,505.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with an ultimate completion date of June 25, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it was awarded on June 24, 2024. The contract does not have a set-aside...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The $19,179.94 firm fixed-price delivery order has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 MG TABLET 60S. The contract has a ceiling value of $6,571.81 and runs through August 16, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...